FNDC5 and early-onset autosomal dominant Alzheimer disease: Several new investigations have given evidence for the protective role of Fndc5/irisin in Alzheimer's disease 37, pulmonary ischemia injury 38, bone remodeling 39 and hepatic steatosis 40.